Background: The human cytidine deaminase APOBEC3G (A3G) has been shown to exhibit antiviral function in the absence of its established catalytic function. A thorough molecular understanding of this deamination-independent mechanism is largely unknown. Methodology: We sought out to characterize the A3G protein and identify key regions and domains related to its antiviral function. A library of mutants was constructed and these mutants were examined for antiviral function in a vif-deficient system. 293T cells were transiently cotransfected with proviral DNA and the mutant construct of interest. A3G and viral expression was verified by Western blotting. Viral particles were quantitated, normalized, and then used to infect TZM cells in a single round infectivity assay. Finally, virions were purified and assessed for A3G packaging. Concurrently, the catalytic activity of the mutants was examined using a Rifampicin based E. coli assay. Results: We have identified two novel N-terminal domains that upon mutation confer a significant loss of antiviral function, but not an observable decrease in catalytic function. Conclusions: These novel domains are quite interesting because they appear to play a significant role in antiviral function but not catalytic function. We are currently looking at the evolutionary conservation of these residues to determine whether these identified domains are in fact conserved or whether these domains fall within regions of the A3G protein that have been subjected to episodes of positive selection.